跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,937 条关于
“Chugai Pharma Taiwan”
全部
10,937
临床试验
4,782
药物
1,201
机构
1,290
资讯
3,664
11个月前
Chugai Launches PiaSky as Taiwan's First Subcutaneous Treatment for Paroxysmal Nocturnal Hemoglobinuria
去年
Taiwan Approves Chugai's PiaSky as First Subcutaneous Treatment for Paroxysmal Nocturnal Hemoglobinuria
10个月前
Chugai Pharmaceutical Acquires Renalys Pharma for $98 Million to Expand Kidney Disease Portfolio
去年
Nxera Pharma Partners with Holling Bio-Pharma to Launch Daridorexant for Insomnia in Taiwan
9个月前
Chugai Pharmaceutical Establishes U.S. Partnering Office to Accelerate Global Open Innovation Strategy
去年
Lantern Pharma Expands LP-300 Trial to Taiwan for Never-Smoker NSCLC
2个月前
Chugai and UCSF Establish Master Collaboration Agreement for Drug Discovery Research
7个月前
Chugai Pharmaceutical Licenses Araris' AraLinQ Technology for Next-Generation ADC Development
9个月前
Chugai Secures Japanese Approval for Tecentriq in Rare Thymic Carcinoma
4个月前
Chugai Files for Japanese Approval of Sparsentan for IgA Nephropathy, Citing Significant Proteinuria Reduction
第 1 页,共 367 页
上一页
下一页